Research Article
Pulmonary Venous Index as Additional Diagnostic Criteria for Fontan Palliation
Table 2
The main clinical parameters of patients.
| | Survivors (n = 55) | Dead (n = 8) | (Mann–Whitney t test) | M ± SD | M ± SD | Me (Q1–Q3) | Me (Q1–Q3) |
| Age (yrs.) | 8.6 ± 4.4 | 9.6 ± 7.3 | | 7.0 (6–10) | 6.5 (5.5–13) |
| BSA (mm2) | 0.93 ± 0.27 | 1.04 ± 0.53 | | 0.88 (0.8−1) | 0.8 (0.7−1.4) |
| SVEF (%) | 61.7 ± 5.4 | 61.8 ± 5.5 | | 60 (60–64) | 62 (59–65) |
| SpO2 (%) | 79.8 ± 5.6 | 71.8 ± 4.6 | | 81 (78–84) | 74 (71.5–81.25) |
| Hb (g/l) | 173.3 ± 22.6 | 193.3 ± 29.7 | | 156 (144–168) | 162.5 (159.25–167.75) |
| PAI (Nakata) (mm2/m2) | 291.3 ± 117.8 | 277.5 ± 141.5 | | 270 (206.3–345.6) | 254 (183.2–396.3) |
| McGoon index | 2.6 ± 0.7 | 2.5 ± 0.6 | | 2.4 (2.0–3.1) | 2.4 (2.0–2.9) |
| PAP (mmHg) | 11.4 ± 2.5 | 13.1 ± 3.3 | | 11 (10–13) | 12.5 (9.5–14) |
| Severe AVVR | 5 | 3 | |
| NYHA FC | III-IV | III-IV | |
|
|
SVEF, single ventricle ejection fraction, BSA, body surface area, PAI, pulmonary arterial index, PAP, pulmonary arterial pressure, and AVVR, atrioventricular valve regurgitation.
|